Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

DME Stakeholders Take CMS To Task For HCPCS Coding Decisions

This article was originally published in The Gray Sheet

  • News

Executive Summary

In advance of public meetings this week, durable medical equipment manufacturers charge that CMS makes it too difficult to obtain new HCPCS codes for their products

You may also be interested in...



CMS Denies Most New Code Requests For Durable Medical Equipment

CMS proposed May 2 to grant 5 of 40 requests for new codes to classify durable medical equipment in 2009

CMS Denies Most New Code Requests For Durable Medical Equipment

CMS proposed May 2 to grant 5 of 40 requests for new codes to classify durable medical equipment in 2009

Frustrated Manufacturers Will Go To HCPCS Meetings With Few Expectations

Medical equipment manufacturers are pushing CMS to establish a more open and responsive process for assigning new reimbursement claims codes following what they consider to be fresh round of unwarranted coding denials for 2008

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight
Tags:
Latest Headlines

Second EU MDR Notified Body Designated In France

Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217

CDS Final Guidance Draws More Criticism, This Time From Congress

Alarming Rise Of Diabetes in Several US States, Study Shows

See All
UsernamePublicRestriction

Register

MT023471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By